Explore
Validate
LearnABIN401281
antibody from antibodies-online
Targeting: GLI3
ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN401281 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-GLI Family Zinc Finger 3 (GLI3) (AA 41-57) antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide corresponding to amino acids 41-57 of Human Gli-3 protein
- Description
- Immunoaffinity Chromatography.
- Reactivity
- Human, Mouse, Rat, Canine, Chicken/Avian, Simian, Xenopus
- Host
- Rabbit
- Epitope
- AA 41-57
- Isotype
- IgG
- Vial size
- 0.1 mg
- Concentration
- 1.0 mg/mL (by UV absorbance at 280 nm)
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at-20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Acute lymphoblastic leukemia in a patient with Greig cephalopolysyndactyly and interstitial deletion of chromosome 7 del(7)(p11.2 p14) involving the GLI3 and ZNFN1A1 genes.
Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations.
Clinical and molecular delineation of the Greig cephalopolysyndactyly contiguous gene deletion syndrome and its distinction from acrocallosal syndrome.
Mendoza-Londono R, Kashork CD, Shaffer LG, Krance R, Plon SE
Genes, chromosomes & cancer 2005 Jan;42(1):82-6
Genes, chromosomes & cancer 2005 Jan;42(1):82-6
Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations.
Johnston JJ, Olivos-Glander I, Killoran C, Elson E, Turner JT, Peters KF, Abbott MH, Aughton DJ, Aylsworth AS, Bamshad MJ, Booth C, Curry CJ, David A, Dinulos MB, Flannery DB, Fox MA, Graham JM, Grange DK, Guttmacher AE, Hannibal MC, Henn W, Hennekam RC, Holmes LB, Hoyme HE, Leppig KA, Lin AE, Macleod P, Manchester DK, Marcelis C, Mazzanti L, McCann E, McDonald MT, Mendelsohn NJ, Moeschler JB, Moghaddam B, Neri G, Newbury-Ecob R, Pagon RA, Phillips JA, Sadler LS, Stoler JM, Tilstra D, Walsh Vockley CM, Zackai EH, Zadeh TM, Brueton L, Black GC, Biesecker LG
American journal of human genetics 2005 Apr;76(4):609-22
American journal of human genetics 2005 Apr;76(4):609-22
Clinical and molecular delineation of the Greig cephalopolysyndactyly contiguous gene deletion syndrome and its distinction from acrocallosal syndrome.
Johnston JJ, Olivos-Glander I, Turner J, Aleck K, Bird LM, Mehta L, Schimke RN, Heilstedt H, Spence JE, Blancato J, Biesecker LG
American journal of medical genetics. Part A 2003 Dec 15;123A(3):236-42
American journal of medical genetics. Part A 2003 Dec 15;123A(3):236-42
No comments: Submit comment
No validations: Submit validation data